[123I]-β-CIT SPECT Imaging Shows Reduced Thalamus–Hypothalamus Serotonin Transporter Availability in 24 Drug-Free Obsessive-Compulsive Checkers
暂无分享,去创建一个
Kurt Hornik | Martin Aigner | K. Hornik | T. Wenzel | K. Thau | M. Aigner | W. Zitterl | T. Stompe | K. Zitterl-Eglseer | K. Gutiérrez-Lobos | B. Schmidl-Mohl | U. Demal | G. Zettinig | Georg Zettinig | Werner Zitterl | Thomas Stompe | Karin Zitterl-Eglseer | Karin Gutierrez-Lobos | Brigitte Schmidl-Mohl | Thomas Wenzel | Ulrike Demal | Kenneth Thau
[1] Marco Leyton,et al. Lack of Effects on Core Obsessive-Compulsive Symptoms of Tryptophan Depletion During Symptom Provocation in Remitted Obsessive-Compulsive Disorder Patients , 2006, Biological Psychiatry.
[2] E. Storch,et al. Clinical predictors of early fluoxetine treatment response in obsessive–compulsive disorder , 2006, Depression and anxiety.
[3] Y. Reddy,et al. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. , 2005, The Journal of clinical psychiatry.
[4] C. Halldin,et al. Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2 , 2005, European Neuropsychopharmacology.
[5] I. Podreka,et al. β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo , 2005, Journal of Neural Transmission / General Section JNT.
[6] J. Kornhuber,et al. SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT. Binding kinetics in the human brain , 2005, Journal of Neural Transmission / General Section JNT.
[7] N. V. D. Van der Wee,et al. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. , 2004, The American journal of psychiatry.
[8] U. Müller,et al. Reduced serotonin transporter–availability in obsessive–compulsive disorder (OCD) , 2004, European Archives of Psychiatry and Clinical Neuroscience.
[9] Esko Vanninen,et al. Initial experience with single-photon emission tomography using iodine-123-labelled 2 β-carbomethoxy-3β-(4-iodophenyl)tropane in human brain , 1993, European Journal of Nuclear Medicine.
[10] E. Hollander,et al. Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. , 2004, The Journal of clinical psychiatry.
[11] H. Möller,et al. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder , 2003, Biological Psychiatry.
[12] Mark Slifstein,et al. Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [11C]McN 5652 , 2003, Biological Psychiatry.
[13] S. Kasper,et al. [123I] β-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa , 2001, Biological Psychiatry.
[14] S. Rauch,et al. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. , 2000, The Psychiatric clinics of North America.
[15] J. Seibyl,et al. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. , 2000, The American journal of psychiatry.
[16] Alexander Neumeister,et al. [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder , 2000, Biological Psychiatry.
[17] J Tauscher,et al. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] S. Rauch,et al. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. , 1999, The American journal of psychiatry.
[19] Linda Carpenter,et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography , 1998, Biological Psychiatry.
[20] R Coppola,et al. Reduced central serotonin transporters in alcoholism. , 1998, The American journal of psychiatry.
[21] Andreas Heinz,et al. Tourette's syndrome , 1998, Neurology.
[22] A L Brody,et al. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder , 1998, British Journal of Psychiatry.
[23] H. Baumgarten,et al. Role of serotonin in obsessive-compulsive disorder , 1998, British Journal of Psychiatry.
[24] E. Hollander,et al. SSRIs in the Treatment of obsessive‐compulsive disorder , 1998, Depression and anxiety.
[25] P. Hof,et al. [3H]Nisoxetine binding sites in the cat brain: An autoradiographic study , 1995, Neuroscience.
[26] Robert B. Innis,et al. Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] C. McDougle,et al. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. , 1994, Archives of general psychiatry.
[28] D. Mash,et al. Visualizing Dopamine and Serotonin Transporters in the Human Brain with the Potent Cocaine Analogue [125I]RTI‐55: In Vitro Binding and Autoradiographic Characterization , 1994, Journal of neurochemistry.
[29] C. Halldin,et al. Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brain , 1994, Synapse.
[30] Suck-Won Kim,et al. The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.
[31] Marc Laruelle,et al. SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates , 1993, Synapse.
[32] E. John,et al. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder , 1993, Psychiatry Research: Neuroimaging.
[33] T. Insel,et al. Toward a neuroanatomy of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.
[34] F I Carroll,et al. High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brain , 1992, Synapse.
[35] C. McDougle,et al. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder , 1992, International clinical psychopharmacology.
[36] S. Tejani-butt. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. , 1992, The Journal of pharmacology and experimental therapeutics.
[37] E. Hollander,et al. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. , 1992, Archives of general psychiatry.
[38] P B Hoffer,et al. [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. , 1991, Journal of medicinal chemistry.
[39] M Laruelle,et al. Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT. , 1991, European journal of pharmacology.
[40] J. Krystal,et al. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. , 1990, Archives of general psychiatry.
[41] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[42] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.
[43] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.
[44] G. Vauquelin,et al. [3H]GBR 12935 Binding to Dopamine Uptake Sites in the Human Brain , 1989, Journal of neurochemistry.
[45] J. Marcusson,et al. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue , 1989, Brain Research.
[46] T. Insel,et al. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. , 1988, Archives of general psychiatry.
[47] J. Rapoport,et al. Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison. , 1988, Psychopharmacology bulletin.
[48] T. Insel,et al. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. , 1987, Archives of general psychiatry.
[49] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[50] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.